{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:08:05Z","timestamp":1766167685825,"version":"3.48.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03605-3","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T03:07:48Z","timestamp":1749179268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and risk factors of ocular hypertension following \u0131ntravitreal dexamethasone implantation: the role of baseline intraocular pressure"],"prefix":"10.1007","volume":"45","author":[{"given":"Elif","family":"Ertan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130dil","family":"\u00c7elen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengiz","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"3605_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","volume":"58","author":"W Kiddee","year":"2013","unstructured":"Kiddee W, Trope GE, Sheng L, Beltran-Agullo L, Smith M, Strungaru MH, Baath J, Buys YM (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58:291\u2013310","journal-title":"Surv Ophthalmol"},{"key":"3605_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archophthalmol.2010.21","volume":"128","author":"JA Haller","year":"2010","unstructured":"Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C et al (2010) Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 128:289\u2013296","journal-title":"Arch Ophthalmol"},{"key":"3605_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.824790","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Ren X, Chen D (2022) Steroid treatment in macular edema: a bibliometric study and visualization analysis. Front Pharmacol 13:824790","journal-title":"Front Pharmacol"},{"issue":"22","key":"3605_CR4","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.3390\/jcm10225300","volume":"10","author":"A Grzybowski","year":"2021","unstructured":"Grzybowski A, Markeviciute A, Zemaitiene R (2021) Treatment of macular edema in vascular retinal diseases: a 2021 update. J Clin Med 10(22):5300","journal-title":"J Clin Med"},{"key":"3605_CR5","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1097\/IAE.0000000000003080","volume":"41","author":"A Rezkallah","year":"2020","unstructured":"Rezkallah A, Mathis T, Abukhashabah A, Voirin N, Malcl\u00e8s A, Agard \u00c9, Lereuil T, Denis P, Dot C, Kodjikian L (2020) Long-term incidence and risk factors of ocular hypertension following dexamethasone-implant injections. The SAFODEX-2 study. Retina 41:1438\u20131445","journal-title":"Retina"},{"issue":"2","key":"3605_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","volume":"11","author":"S Phulke","year":"2017","unstructured":"Phulke S, Kaushik S, Kaur S, Pandav SS (2017) Steroid-induced Glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract 11(2):67\u201372","journal-title":"J Curr Glaucoma Pract"},{"key":"3605_CR7","first-page":"353","volume":"75","author":"GL Spaeth","year":"1977","unstructured":"Spaeth GL, Rodrigues MM, Weinreb S (1977) Steroid-induced glaucoma: A. Persistent elevation of intraocular pressure B. Histopathological aspects. Trans Am Ophthalmol Soc 75:353\u2013381","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3605_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1350-9462(98)00035-4","volume":"18","author":"RJ Wordinger","year":"1999","unstructured":"Wordinger RJ, Clark AF (1999) Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res 18:629\u2013667","journal-title":"Prog Retin Eye Res"},{"key":"3605_CR9","first-page":"1274","volume":"24","author":"MF Armaly","year":"1965","unstructured":"Armaly MF, Becker B (1965) Intraocular pressure response to topical corticosteroids. Fed Proc 24:1274\u20131278","journal-title":"Fed Proc"},{"key":"3605_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR et al (2002) The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714\u2013720","journal-title":"Arch Ophthalmol"},{"key":"3605_CR11","doi-asserted-by":"crossref","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134\u20131146. e1133.","DOI":"10.1016\/j.ophtha.2010.03.032"},{"key":"3605_CR12","doi-asserted-by":"crossref","unstructured":"Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, et al. Ozurdex CHAMPLAIN Study Group (2011) Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 31:915\u201323.","DOI":"10.1097\/IAE.0b013e318206d18c"},{"issue":"4","key":"3605_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00417-023-06299-4","volume":"262","author":"WJ Cho","year":"2024","unstructured":"Cho WJ, Lee JM, Bae HW, Kim CY, Seong GJ, Choi W (2024) Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant. Graefes Arch Clin Exp Ophthalmol 262(4):1231\u20131243","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"3605_CR14","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/IAE.0000000000001369","volume":"37","author":"A Malcl\u00e8s","year":"2017","unstructured":"Malcl\u00e8s A, Dot C, Voirin N, Vi\u00e9 AL, Agard \u00c9, Bellocq D, Denis P, Kodjikian L (2017) Safety of intravitreal dexamethasone implant (OZURDEX): the SAFODEX study Incidence and risk factors of ocular hypertension. Retina 37(7):1352\u20131359","journal-title":"Retina"},{"key":"3605_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/aos.17475","author":"I Abu Ishkheidem","year":"2025","unstructured":"Abu Ishkheidem I, Breimer M, Kamal S, Zetterberg M, Al-Hawasi A, Gr\u00f6nlund MA (2025) Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: a retrospective Swedish cohort study. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.17475","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"3605_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bjo.2006.090340","volume":"90","author":"DJ Rhee","year":"2006","unstructured":"Rhee DJ, Peck RE, Belmont J, Martidis A, Liu M, Chang J, Fontanarosa J, Moster MR (2006) Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 90(8):999\u20131003","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3605_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000492132","volume":"241","author":"P Mello Filho","year":"2019","unstructured":"Mello Filho P, Andrade G, Maia A, Maia M, BiccasNeto L, MuralhaNeto A, Moura Brasil O, Minelli E, Dalloul C, Iglicki M (2019) Effectiveness and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: a real-world experience. Ophthalmologica 241(1):9\u201316. https:\/\/doi.org\/10.1159\/000492132","journal-title":"Ophthalmologica"},{"key":"3605_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/IAE.0000000000001364","volume":"37","author":"EK Chin","year":"2017","unstructured":"Chin EK, Almeida DRP, Velez G, Xu K, Peraire M, Corbella M, Elshatory YM, Kwon YH, Gehrs KM, Boldt HC, Sohn EH, Russell SR, Folk JC, Mahajan VB (2017) Ocular hypertension after intravitreal dexamethasone (Ozurdex) sustained-release implant. Retina 37:1345\u20131351","journal-title":"Retina"},{"key":"3605_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000438759","volume":"54","author":"S Mazzarella","year":"2015","unstructured":"Mazzarella S, Mateo C, Freixes S, Bur\u00e9s-Jelstrup A, Rios J, Navarro R, Garc\u00eda-Arum\u00ed J, Corc\u00f3stegui B, Arrondo E (2015) Effect of intravitreal injection of dexamethasone 0.7\u00a0mg (Ozurdex(R)) on intraocular pressure in patients with macular edema. Ophthalmic Res 54:143\u2013149","journal-title":"Ophthalmic Res"},{"issue":"3","key":"3605_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4103\/ojo.ojo_326_21","volume":"15","author":"T Mansoori","year":"2022","unstructured":"Mansoori T, Shiva S, Balakrishna N (2022) Ocular hypertension and its predictor after a single Ozurdex implant: one-year follow-up in Asian Indian eyes. Oman J Ophthalmol 15(3):299\u2013303","journal-title":"Oman J Ophthalmol"},{"issue":"38","key":"3605_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2025.102274","volume":"7","author":"J Xiao","year":"2025","unstructured":"Xiao J, Qiu M (2025) Management of ocular hypertension following intravitreal dexamethasone implant (ozurdex). Am J Ophthalmol Case Rep 7(38):102274","journal-title":"Am J Ophthalmol Case Rep"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03605-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:03:28Z","timestamp":1766167408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03605-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3605"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03605-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"233"}}